<DOC>
	<DOCNO>NCT01125215</DOCNO>
	<brief_summary>The objective study determine efficacy safety 0.75 % topical capsaicin nanoparticle preparation versus placebo patient painful diabetic neuropathy .</brief_summary>
	<brief_title>Capsaicin Nanoparticle Patient With Painful Diabetic Neuropathy</brief_title>
	<detailed_description>Painful diabetic neuropathy common cause neuropathic pain . 0.075 % topical capsaicin use treat pain . Because high concentration , conventional capsaicin topical preparation cause burn sensation require several time application per day . The nanoparticle capsaicin topical preparation develop expectation remain efficacy , minimize burn sensation improve convenience use .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>History type 2 Diabetes mellitus Peripheral neuropathy Stabilized pain medication least one month No previous invasive intervention pain relief Local wound skin abnormality applicable area Allergic capsaicin Refuse participate give consent Has significant disease receive medication may worsen neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Painful diabetic neuropathy</keyword>
	<keyword>Capsaicin</keyword>
	<keyword>Nanoparticle</keyword>
	<keyword>Quantitative Sensory Testing</keyword>
</DOC>